Hum. Reprod. Advance Access published online on June 2, 2005
Human Reproduction, doi:10.1093/humrep/dei093
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Endocrinology, Mubarak Al-Kabeer Hospital and Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait
* To whom correspondence should be addressed. BACKGROUND: This cross-sectional study was undertaken to evaluate the factors that relate to menstrual status (oligo-amenorrhoea versus eumenorrhoea) in polycystic ovary syndrome (PCOS). METHODS: A total of 234 women with clinical and biochemical features suggestive of PCOS underwent metabolic and hormonal evaluation. A forward stepwise logistic regression model was created based on the results to determine variables related to ovulatory status. RESULTS: Only follicular phase progesterone and estradiol (E2) were retained in the final model. This model correctly classified 80% of PCOS women by ovulatory status. Univariate analysis revealed no difference in progesterone between ovulatory groups but E2 was higher in anovulatory groups. This suggested interaction between progesterone and E2 and the single interaction variable (progesterone/E2) also classified 80% of women by ovulatory status correctly. CONCLUSION: The results suggest that a low ratio of progesterone to E2 is associated with menstrual irregularity and ovulatory status in PCOS.
Received January 24, 2005
Revised February 21, 2005
Accepted April 14, 2005
Article
Irregular cycles and steroid hormones in polycystic ovary syndrome
2 Radioimmunoassay Laboratory, Mubarak Al-Kabeer Hospital, Kuwait
3 School of Biomedical Sciences, Charles Sturt University, Australia
Suhail A.R. Doi, E-mail: sardoi{at}gmx.net
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. Sander, C. G. Luchetti, M. E. Solano, E. Elia, G. Di Girolamo, C. Gonzalez, and A. B. Motta Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction, March 1, 2006; 131(3): 591 - 602. [Abstract] [Full Text] [PDF] |
||||
